{"entity":{"type":"insider","cik":"0001671870","url":"/insider/0001671870","json_url":"/insider/0001671870.json","name":"Rivera Jose E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":13,"first":"2020-05-28","last":"2021-04-02","span_basis":"filed_date"},"name_variants":[{"name":"Rivera Jose E","source":"filing","n_filings":13,"first_seen":"2020-05-28","last_seen":"2021-04-02"}],"transactions":[{"id":4727684,"accession":"0001209191-21-024888","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-21-024888","line_url":"/filing/0001209191-21-024888","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50455.0,"shares_display":"50,455","price_per_share":82.46078783074026,"price_display":"82.46","price_state":"stated","total_value":4160559.05,"total_display":"4,160,559.05","total_whole":"4,160,559","shares_owned_after":138566.0,"shares_owned_after_display":"138,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider","n_lines":21},{"id":5035420,"accession":"0001209191-21-009085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009085","line_url":"/filing/0001209191-21-009085#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11489.0,"shares_display":"11,489","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":861675.0,"total_display":"861,675.00","total_whole":"861,675","shares_owned_after":117920.0,"shares_owned_after_display":"117,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":5465748,"accession":"0001209191-21-007637","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-007637","line_url":"/filing/0001209191-21-007637","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54659.0,"shares_display":"54,659","price_per_share":63.99499588356904,"price_display":"63.99","price_state":"stated","total_value":3497902.48,"total_display":"3,497,902.48","total_whole":"3,497,902","shares_owned_after":93998.0,"shares_owned_after_display":"93,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider","n_lines":9},{"id":4221211,"accession":"0001209191-21-001712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-001712","line_url":"/filing/0001209191-21-001712#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2078.0,"shares_display":"2,078","price_per_share":55.86,"price_display":"55.86","price_state":"stated","total_value":116077.08,"total_display":"116,077.08","total_whole":"116,077","shares_owned_after":51990.0,"shares_owned_after_display":"51,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-05","scope":"insider"},{"id":2346392,"accession":"0001209191-20-061650","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-061650","line_url":"/filing/0001209191-20-061650","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3364.0,"shares_display":"3,364","price_per_share":38.206019619500594,"price_display":"38.21","price_state":"stated","total_value":128525.05,"total_display":"128,525.05","total_whole":"128,525","shares_owned_after":50487.0,"shares_owned_after_display":"50,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider","n_lines":3},{"id":2739426,"accession":"0001209191-20-059272","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-059272","line_url":"/filing/0001209191-20-059272#line-7","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":21840.0,"total_display":"21,840.00","total_whole":"21,840","shares_owned_after":47072.0,"shares_owned_after_display":"47,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-18","scope":"insider"},{"id":2739417,"accession":"0001209191-20-059272","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-059272","line_url":"/filing/0001209191-20-059272","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6029.0,"shares_display":"6,029","price_per_share":34.28901144468403,"price_display":"34.29","price_state":"stated","total_value":206728.45,"total_display":"206,728.45","total_whole":"206,728","shares_owned_after":46700.0,"shares_owned_after_display":"46,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider","n_lines":3},{"id":2797395,"accession":"0001209191-20-057300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-057300","line_url":"/filing/0001209191-20-057300#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3364.0,"shares_display":"3,364","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":94192.0,"total_display":"94,192.00","total_whole":"94,192","shares_owned_after":42315.0,"shares_owned_after_display":"42,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":2444574,"accession":"0001209191-20-055196","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-055196","line_url":"/filing/0001209191-20-055196","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":24.2000017809439,"price_display":"24.20","price_state":"stated","total_value":135883.01,"total_display":"135,883.01","total_whole":"135,883","shares_owned_after":40835.0,"shares_owned_after_display":"40,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider","n_lines":2},{"id":2192019,"accession":"0001209191-20-050945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050945","line_url":"/filing/0001209191-20-050945#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":21.04,"price_display":"21.04","price_state":"stated","total_value":118139.6,"total_display":"118,139.60","total_whole":"118,140","shares_owned_after":36294.0,"shares_owned_after_display":"36,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-17","scope":"insider"},{"id":3116337,"accession":"0001209191-20-047713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047713","line_url":"/filing/0001209191-20-047713#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":117915.0,"total_display":"117,915.00","total_whole":"117,915","shares_owned_after":31909.0,"shares_owned_after_display":"31,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2370804,"accession":"0001209191-20-042820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042820","line_url":"/filing/0001209191-20-042820#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":22.7,"price_display":"22.70","price_state":"stated","total_value":127460.5,"total_display":"127,460.50","total_whole":"127,461","shares_owned_after":27524.0,"shares_owned_after_display":"27,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":3089863,"accession":"0001209191-20-037647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037647","line_url":"/filing/0001209191-20-037647#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":117915.0,"total_display":"117,915.00","total_whole":"117,915","shares_owned_after":22282.0,"shares_owned_after_display":"22,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"},{"id":2286679,"accession":"0001209191-20-032648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032648","line_url":"/filing/0001209191-20-032648#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001671870","owner_name":"Rivera Jose E","owner_display_name":"Rivera Jose E","owner_url":"/insider/0001671870","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":21.21,"price_display":"21.21","price_state":"stated","total_value":119094.15,"total_display":"119,094.15","total_whole":"119,094","shares_owned_after":280107.0,"shares_owned_after_display":"280,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Officer (EVP, General Counsel)","n_filings":13,"first_seen":"2020-05-28","last_seen":"2021-04-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001671870","retrieved_at":"2026-08-25T07:19:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}